Literature DB >> 443970

Sampling variability on percutaneous liver biopsy.

W Abdi, J C Millan, E Mezey.   

Abstract

Sampling variability of liver biopsy was determined in three consecutive biopsy specimens obtained from each of 118 patients immediately prior to autopsy. No sampling variability was found for fatty liver, alcoholic hepatitis, nonspecific hepatitis, fulminant hepatitis, leukemic infiltrate, and venous congestion. Cirrhosis was diagnosed in 80% of cases at the first biopsy but in all cases after three biopsies. Chronic aggressive and chronic persistent hepatitis were diagnosed correctly in two of three cases each at the first biopsy, and in all cases after three biopsies. Metastatic carcinoma was detected in 46% of cases at the first biopsy and in 69% after three biopsies. Granulomas were missed once on the first biopsy, but found on a subsequent biopsy. The amounts of fat and fibrosis in the biopsy specimens often were not representative of the amounts present at autopsy.

Entities:  

Mesh:

Year:  1979        PMID: 443970

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  70 in total

Review 1.  Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.

Authors:  Scott B Reeder; Irene Cruite; Gavin Hamilton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-09-16       Impact factor: 4.813

Review 2.  Quantification of liver fat with magnetic resonance imaging.

Authors:  Scott B Reeder; Claude B Sirlin
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

Review 3.  Needle biopsy of the liver. A critique of four currently available methods.

Authors:  R R Babb; R J Jackman
Journal:  West J Med       Date:  1989-01

4.  Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.

Authors:  Tadashi Takeda; Takahiro Yasuda; Yuji Nakayama; Mika Nakaya; Megumi Kimura; Mariko Yamashita; Ayumi Sawada; Koji Abo; Setsuko Takeda; Hiroki Sakaguchi; Susumu Shiomi; Hitoshi Asai; Shuichi Seki
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

5.  Clinical Utility of Biomarkers of Liver Fibrosis.

Authors:  Keyur Patel; Don C Rockey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

6.  Detection of novel biomarkers of liver cirrhosis by proteomic analysis.

Authors:  Christian Mölleken; Barbara Sitek; Corinna Henkel; Gereon Poschmann; Bence Sipos; Sebastian Wiese; Bettina Warscheid; Christoph Broelsch; Markus Reiser; Scott L Friedman; Ida Tornøe; Anders Schlosser; Günter Klöppel; Wolff Schmiegel; Helmut E Meyer; Uffe Holmskov; Kai Stühler
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

7.  Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Authors:  Janani Arun; Niraj Jhala; Audrey J Lazenby; Ronald Clements; Gary A Abrams
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

8.  Integrated quantitative susceptibility and R2 * mapping for evaluation of liver fibrosis: An ex vivo feasibility study.

Authors:  Ramin Jafari; Stefanie J Hectors; Anne K Koehne de González; Pascal Spincemaille; Martin R Prince; Gary M Brittenham; Yi Wang
Journal:  NMR Biomed       Date:  2020-09-22       Impact factor: 4.044

9.  Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals.

Authors:  J C Hoefs; D Aufrichtig; S Lottenberg; G C Kanel; B S Donner; L A Ferrari; S Leeman; R M Friedenberg
Journal:  Dig Dis Sci       Date:  1986-10       Impact factor: 3.199

10.  Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

Authors:  Antonio Ramos-De la Medina; José M Remes-Troche; Federico B Roesch-Dietlen; Alfonso G Pérez-Morales; Silvia Martinez; Silvia Cid-Juarez
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.